Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?



VolitionRX Ltd. (VNRX)

This text will be replaced


Cameron Reynolds of VolitionRX Ltd. ($VNRX) sits down with Equities.com to discuss the company's blood-based diagnostic tests for cancer.

This video interview may include forward-looking statements that involve risks and uncertainties. Forward- looking statements are statements that are not historical facts and are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. To read our full disclosure, please go to: http://www.equities.com/disclaimer.
Back to Top

Popular Video

Gerald Commissiong, CEO Amarantus...

Joe Beyers, Chairman and CEO Inventergy

Robert Ehrlich, Chairman and CEO...

Targeted Medical Pharma, Inc. (OTC:...

BSD Medical Corp. (NASDAQ: BSDM)

View all



blog comments powered by Disqus

 Today's Must Reads

What Crowdfunding Leaders Are Saying About the SEC’s Approval of Title III

How the Drug Price Scrutiny is Affecting Pharma Stocks

8 More Tips for Choosing the Right Crowdfunding Platform

Will the Post-Smartphone Era Bring Wearable Drones?

3 Cloud Stocks That Pay Dividends


Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register